These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2005-000666-39 A Controlled, Randomized, Open label Phase II Trial to Evaluate Safety and Efficacy of a 1st line Combination Treatment with Weekly Infusion of Gemcitabine and Twice Weekly Administration of Lipid Com... 2008-10-24 due-trials
Ongoing 2006-002221-23 An open-label, randomized, controlled Phase-II trial evaluating the efficacy and safety of EndoTAG-1 in triple receptor negative breast cancer patients not-yet-due
Reported results 2006-004398-89 Comparative Study of the Efficacy of 10 mg Dequalinium Chloride (Fluomizin®) in the Local Treatment of Bacterial Vaginosis 2008-08-28 due-trials
Reported results 2006-004399-11 The Efficacy of 10 mg Dequalinium Chloride (Fluomizin®) in the Local Treatment of Aerobic Bacterial Vaginal Infections in Comparison to Placebo 2009-05-13 due-trials
Not reported 2007-004038-18 An open-label, uncontrolled, Phase II trial evaluating the single-dose and steady-state pharmacokinetics of EndoTAG®-1 and its effect on the blood supply and the angiogenesis of hepatic metastases in ... 2009-08-14 due-trials
Exempt Terminated 2017-000440-18 A Phase I/II, Open-Label, Non-Randomized, Multicentre, Dose-Escalation Clinical Trial with Control Group to Evaluate the Safety, Feasibility and Preliminary Efficacy of PRAME TCR Modified T Cells, MDG... 2022-07-15 not-yet-due
Not reported 2018-000717-20 Long-Term Follow-Up Clinical Trial of Subjects Treated with PRAME TCR modified T cells, MDG1011 2022-12-12 due-trials
Reported results Terminated 2020-002489-15 Comparative study of the efficacy and safety of vaginally applied Dequalinium Chloride (10 mg) and orally applied Metronidazole (2 x 500 mg) in the treatment of bacterial vaginosis Komparativní kli... 2022-08-25 due-trials